hsp70 and a novel axis of type I interferon-dependent antiviral immunity in the measles virus-infected Brain

Journal of Virology

Volumn 87, Issue 2, 2013, Pages 998-1009

  Kim, Mi Young ^a   Shu, Yaoling ^a   Carsillo, Thomas ^a   Zhang, Jianying ^a   Yu, Lianbo ^a   Peterson, Cornelia ^a   Longhi, Sonia ^b   Girod, Sarah ^a   Niewiesk, Stefan ^a   Oglesbee, Michael ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; HEAT SHOCK PROTEIN 70; I KAPPA B KINASE ALPHA; INTERFERON; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; RETINOIC ACID INDUCIBLE PROTEIN I; RIBONUCLEASE L; STAT1 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BRAIN INFECTION; CHUK GENE; CONTROLLED STUDY; FEMALE; GENE; GENE DOSAGE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; HEAT SHOCK PROTEIN 70 GENE; IFI27 GENE; IFIT1L GENE; INNATE IMMUNITY; IRF7 GENE; IRF9 GENE; MACROPHAGE ACTIVATION; MALE; MEASLES; MEASLES VIRUS; MICROGLIA; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RIG 1 GENE; RNASE L GENE; SIGNAL TRANSDUCTION; STAT 1 GENE; TGTP GENE; TOLL LIKE RECEPTOR 2 GENE; TOLL LIKE RECEPTOR 4 GENE; TRANSGENIC MOUSE; USP18 GENE; VIRUS IMMUNITY;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HSP70 HEAT-SHOCK PROTEINS; INTERFERON TYPE I; MACROPHAGES; MALE; MEASLES; MEASLES VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TRANSCRIPTOME;

MEASLES VIRUS; MUS;

EID: 84871958894     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02710-12     Document Type: Article

References (78)

1. Morrison-Bogorad M, Zimmerman AL, Pardue S. 1995. Heat-shock 70 messenger RNA levels in human brain: correlation with agonal fever. J. Neurochem. 64:235-246.
2. Hutchins SS, Papania MJ, Amler R, Maes EF, Grabowsky M, Bromberg K, Glasglow V, Speed T, Bellini WJ, Orenstein WA. 2004. Evaluation of the measles clinical case definition. J. Infect. Dis. 189(Suppl 1):S153-S159.
3. Mackowiak PA. 1994. Fever: blessing or curse? A unifying hypothesis. Ann. Intern. Med. 120:1037-1040.
4. Mackowiak PA. 2000. Physiological rationale for suppression of fever. Clin. Infect. Dis. 31(Suppl 5):S185-S189.
5. Milner CM, Campbell RD. 1990. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 32:242-251.
6. Wells AD, Rai SK, Salvato MS, Band H, Malkovsky M. 1998. Hsp72- mediated augmentation of MHC class I surface expression and endogenous antigen presentation. Int. Immunol. 10:609-617.
7. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. 2000. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12:1539-1546.
8. Vega VL, Rodriguez-Silva M, Frey T, Gehrmann M, Diaz JC, Steinem C, Multhoff G, Arispe N, De Maio A. 2008. Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J. Immunol. 180:4299-4307.
9. Carsillo T, Carsillo M, Traylor Z, Rajala-Schultz P, Popovich P, Niewiesk S, Oglesbee M. 2009. Major histocompatibility complex haplotype determines hsp70-dependent protection against measles virus neurovirulence. J. Virol. 83:5544-5555.
10. Carsillo T, Traylor Z, Choi C, Niewiesk S, Oglesbee M. 2006. hsp72, a host determinant of measles virus neurovirulence. J. Virol. 80:11031-11039.
11. Sakae H, Kohase M, Kurata T, Yoshikura H. 1997. Isolation of a measles virus variant: protection of newborn mice from measles encephalitis by 24 h prior intracerebral inoculation with the variant. Arch. Virol. 142:1937-1952.
12. Carsillo T, Carsillo M, Niewiesk S, Vasconcelos D, Oglesbee M. 2004. Hyperthermic pre-conditioning promotes measles virus clearance from brain in a mouse model of persistent infection. Brain Res. 1004:73-82.
13. Oglesbee M, Niewiesk S. 2011. Measles virus neurovirulence and host immunity. Future Virol. 6:85-99.
14. Pardue S, Wang S, Miller MM, Morrison-Bogorad M. 2007. Elevated levels of inducible heat shock 70 proteins in human brain. Neurobiol. Aging 28:314-324.
15. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK. 2002. Novel signal transduction pathway utilized by extracellular HSP70: role of TLR2 and TLR4. J. Biol. Chem. 277:15028-15034.
16. Kakimura J, Kitamura Y, Takata K, Umeki M, Suzuki S, Shibagaki K, Taniguchi T, Nomura Y, Gebicke-Haerter PJ, Smith MA, Perry G, Shimohama S. 2002. Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J. 16:601-603.
17. Beyer SJ, Zhang X, Jimenez RE, Lee ML, Richardson AL, Huang K, Jhiang SM. 2011. Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer. BMC Res. Notes 4:397.
18. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
19. Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl. Genet. Mol. Biol. 3:Article3.
20. Gordon A, Glazko G, Qiu X, Yakovlev A. 2007. Control of the mean number of false discoveries, Bonferroni and stability of multiple testing. Ann. Appl. Stat. 1:179-190.
21. Killedar S, DiRosario J, Divers E, Popovich PG, McCarty DM, Fu HY. 2010. Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response. J. Neuroinflammation 7:39. doi: 10.1186/1742-2094-7-39.
22. Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich PG. 2003. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J. Comp. Neurol. 462:223-240.
23. Kigerl KA, McGaughy VM, Popovich PG. 2006. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J. Comp. Neurol. 494:578-594.
24. Gerlach N, Schimmer S, Weiss S, Kalinke U, Dittmer U. 2006. Effects of type I interferons on Friend retrovirus infection. J. Virol. 80:3438-3444.
25. Müller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
26. Carsillo T, Zhang X, Vasconcelos D, Niewiesk S, Oglesbee M. 2006. A single codon in the nucleocapsid protein C terminus contributes to in vitro and in vivo fitness of Edmonston measles virus. J. Virol. 80:2904-2912.
27. Couturier M, Buccellato M, Costanzo S, Bourhis JM, Shu Y, Nicaise M, Desmadril M, Flaudrops C, Longhi S, Oglesbee M. 2010. High affinity binding between Hsp70 and the C-terminal domain of the measles virus nucleoprotein requires an Hsp40 co-chaperone. J. Mol. Recognit. 23:301-315.
28. Zhang X, Bourhis JM, Longhi S, Carsillo T, Buccellato M, Morin B, Canard B, Oglesbee M. 2005. Hsp72 recognizes a P binding motif in the measles virus N protein C-terminus. Virology 337:162-174.
29. Longbrake EE, Lai W, Ankeny DP, Popovich PG. 2007. Characterization and modeling of monocyte-derived macrophages after spinal cord injury. J. Neurochem. 102:1083-1094.
30. Hoshino K, Sugiyama T, Matsumoto M, Tanaka T, Saito M, Hemmi H, Ohara O, Akira S, Kaisho T. 2006. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 440:949-953.
31. Waddell SJ, Popper SJ, Rubins KH, Griffiths MJ, Brown PO, Levin M, Relman DA. 2010. Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One 5:e9753. doi:10.1371/ journal.pone.0009753.
32. Carlow DA, Teh SJ, Teh HS. 1998. Specific antiviral activity demonstrated by TGTP, a member of a new family of interferon-induced GTPases. J. Immunol. 161:2348-2355.
33. Fischer T, Aman J, van der Kuip H, Rudolf G, Peschel C, Aulitzky WE, Huber C. 1996. Induction of interferon regulatory factors 2'-5' oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness. Br. J. Haematol. 92:595-603.
34. Hui KP, Lee SM, Cheung CY, Mao H, Lai AK, Chan RW, Chan MC, Tu W, Guan Y, Lau YL, Peiris JS. 2011. H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades. J. Infect. Dis. 204:1866-1878.
35. Schmeisser H, Mejido J, Balinsky CA, Morrow AN, Clark CR, Zhao T, Zoon KC. 2010. Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene. J. Virol. 84:10671-10680.
36. Delhaye S, Paul S, Blakqori G, Minet M, Weber F, Staeheli P, Michiels T. 2006. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. U. S. A. 103:7835-7840.
37. Pien GC, Nguyen KB, Malmgaard L, Satoskar AR, Biron CA. 2002. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J. Immunol. 169:5827-5837.
38. Ziegler G, Harhausen D, Schepers C, Hoffmann O, Rohr C, Prinz V, Konig J, Lehrach H, Nietfeld W, Trendelenburg G. 2007. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem. Biophys. Res. Commun. 359:574-579.
39. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:312-318.
40. Lemstra AW, Groenin't Woud JCM, Hoozemans JJM, van Haastert ES, Rozemuller AJM, Eikelenboom P, van Gool WA. 2007. Microglia activation in sepsis: a case-control study. J. Neuroinflammation 4:4. doi: 10.1186/1742-2094-4-4.
41. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. U. S. A. 88:7438-7442.
42. Kallfass C, Ackerman A, Lienenklaus S, Weiss S, Heimrich B, Staeheli P. 2012. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J. Virol. 86:11223-11230.
43. Dhib-Jalbut S, Xia J, Rangaviggula H, Fang YY, Lee T. 1999. Failure of measles virus to activate nuclear factor-kappa B in neuronal cells: implications on the immune response to viral infections in the central nervous system. J. Immunol. 162:4024-4029.
44. Qin H, Wilson CA, Lee SJ, Zhao X, Benveniste EN. 2005. LPS induces CD40 gene expression through the activation of NF-kappaB and STAT- 1alpha in macrophages and microglia. Blood 106:3114-3122.
45. Yuyama K, Sun H, Mitsutake S, Igarashi Y. 2012. Sphingolipidmodulated exosome secretion promotes clearance of amyloid-beta by microglia. J. Biol. Chem. 287:10977-10989.
46. Marini AM, Kozuka M, Lipsky RH, Nowak TS, Jr. 1990. 70-kilodalton heat shock protein induction in cerebellar astrocytes and cerebellar granule cells in vitro: comparison with immunocytochemical localization after hyperthermia in vivo. J. Neurochem. 54:1509-1516.
47. Voisin PJ, Pardue S, Macouillard F, Yehia G, Labouesse J, Morrison- Bogorad M. 1996. Differential expression of heat shock 70 proteins in primary cultures from rat cerebellum. Brain Res. 739:215-234.
48. Oglesbee MJ, Pratt M, Carsillo T. 2002. Role for heat shock proteins in the immune response to measles virus infection. Viral Immunol. 15:399-416.
49. Henn A, Lund S, Hedtjarn M, Schrattenholz A, Porzgen P, Leist M. 2009. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26:83-94.
50. Glaser KC, Hagos B, Molestina RE. 2011. Effects of Toxoplasma gondii genotype and absence of host MAL/Myd88 on the temporal regulation of gene expression in infected microglial cells. Exp. Parasitol. 129:409-413.
51. Schell JB, Crane CA, Smith MF, Jr, Roberts MR. 2007. Differential ex vivo nitric oxide production by acutely isolated neonatal and adult microglia. J. Neuroimmunol. 189:75-87.
52. Robinzon S, Dafa-Berger A, Dyer MD, Paeper B, Proll SC, Teal TH, Rom S, Fishman D, Rager-Zisman B, Katze MG. 2009. Impaired cholesterol biosynthesis in a neuronal cell line persistently infected with measles virus. J. Virol. 83:5495-5504.
53. Awad H, Suntres Z, Heijmans J, Smeak D, Bergdall-Costell V, Christofi FL, Magro C, Oglesbee M. 2008. Intracellular and extracellular expression of the major inducible 70kDa heat shock protein in experimental ischemia-reperfusion injury of the spinal cord. Exp. Neurol. 212:275-284.
54. Campisi J, Leem TH, Fleshner M. 2003. Stress-induced extracellular Hsp72 is a functionally significant danger signal to the immune system. Cell Stress Chaperones 8:272-286.
55. Patterson CE, Lawrence DM, Echols LA, Rall GF. 2002. Immunemediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J. Virol. 76: 4497-4506.
56. Slifka MK, Rodriguez F, Whitton JL. 1999. Rapid on/off cycling of cytokine production by virus-specific CD8 T cells. Nature 401:76-79.
57. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485.
58. Liu SY, Sanchez DJ, Aliyari R, Lu S, Cheng G. 2012. Systematic identification of type I and type II interferon-induced antiviral factors. Proc. Natl. Acad. Sci. U. S. A. 109:4239-4244.
59. Faul EJ, Wanjalla CN, Suthar MS, Gale M, Wirblich C, Schnell MJ. 2010. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog. 6:e1001016. doi:10.1371/journal.ppat.1001016.
60. Beauvillain C, Donnou S, Jarry U, Scotet M, Gascan H, Delneste Y, Guermonprez P, Jeannin P, Couez D. 2008. Neonatal and adult microglia cross-present exogenous antigens. Glia 56:69-77.
61. Manchester M, Eto DS, Oldstone MB. 1999. Characterization of the inflammatory response during acute measles encephalitis in NSE-CD46 transgenic mice. J. Neuroimmunol. 96:207-217.
62. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
63. Matzinger P. 2002. The danger model: a renewed sense of self. Science 296:301-305.
64. Rehli M. 2002. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol. 23:375-378.
65. Moehler M, Zeidler M, Schede J, Rommelaere J, Galle PR, Cornelis JJ, Heike M. 2003. Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells. Cancer Gene Ther. 10:477-480.
66. Meckes DG, Jr, Raab-Traub N. 2011. Microvesicles and viral infection. J. Virol. 85:12844-12854.
67. Anand PK, Anand E, Bleck CK, Anes E, Griffiths G. 2010. Exosomal Hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria. PLoS One 5:e10136. doi:10.1371/journal.pone.0010136.
68. Basu S, Binder RJ, Ramalingam T, Srivastava PK. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303-313.
69. Giraudon P, Buckland R, Wild TF. 1992. The immune response to measles virus in mice. T-helper response to the nucleoprotein and mapping of the T-helper epitopes. Virus Res. 22:41-54.
70. Zhang X, Glendening C, Linke H, Parks CL, Brooks C, Udem SA, Oglesbee M. 2002. Identification and characterization of a regulatory domain on the carboxyl terminus of the measles virus nucleocapsid protein. J. Virol. 76:8737-8746.
71. Chen W, Lin Y, Liao C, Hsieh S. 2000. Modulatory effects of the human heat shock protein 70 on DNA vaccination. J. Biomed. Sci. 7:412-419.
72. Pack CD, Kumaraguru U, Suvas S, Rouse BT. 2005. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus. Vaccine 23:3526-3534.
73. Detje CN, Meyer T, Schmidt H, Kreuz D, Rose JK, Bechmann I, Prinz M, Kalinke U. 2009. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J. Immunol. 182:2297-2304.
74. Faul EJ, Wanjalla CN, McGettigan JP, Schnell MJ. 2008. Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity. Virology 382:226-238.
75. Hefti HP, Frese M, Landis H, Di Paolo C, Aguzzi A, Haller O, Pavlovic J. 1999. Human MxA protein protects mice lacking a functional alpha/ beta interferon system against La Crosse virus and other lethal viral infections. J. Virol. 73:6984-6991.
76. Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, Yoneyama M, Fujita T, Taya C, Yonekawa H, Koike S. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 79:4460-4469.
77. Sainz B, Jr, Halford WP. 2002. Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76:11541-11550.
78. Samuel MA, Diamond MS. 2005. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79:13350-13361.